India
· Delayed Price · Currency is INR Remus Pharmaceuticals Statistics
Total Valuation
NSE:REMUS has a market cap or net worth of INR 10.35 billion. The enterprise value is 10.77 billion.
| Market Cap | 10.35B |
| Enterprise Value | 10.77B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:REMUS has 11.78 million shares outstanding. The number of shares has decreased by -21.35% in one year.
| Current Share Class | 11.78M |
| Shares Outstanding | 11.78M |
| Shares Change (YoY) | -21.35% |
| Shares Change (QoQ) | -48.68% |
| Owned by Insiders (%) | 51.36% |
| Owned by Institutions (%) | n/a |
| Float | 5.62M |
Valuation Ratios
The trailing PE ratio is 26.95.
| PE Ratio | 26.95 |
| Forward PE | n/a |
| PS Ratio | 1.67 |
| PB Ratio | 3.66 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 148.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.57, with an EV/FCF ratio of -260.10.
| EV / Earnings | 37.04 |
| EV / Sales | 1.74 |
| EV / EBITDA | 23.57 |
| EV / EBIT | 24.57 |
| EV / FCF | -260.10 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.82 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.50 |
| Debt / FCF | -5.55 |
| Interest Coverage | 30.01 |
Financial Efficiency
Return on equity (ROE) is 19.86% and return on invested capital (ROIC) is 13.00%.
| Return on Equity (ROE) | 19.86% |
| Return on Assets (ROA) | 7.94% |
| Return on Invested Capital (ROIC) | 13.00% |
| Return on Capital Employed (ROCE) | 14.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 48 |
| Asset Turnover | 1.80 |
| Inventory Turnover | 11.28 |
Taxes
In the past 12 months, NSE:REMUS has paid 89.20 million in taxes.
| Income Tax | 89.20M |
| Effective Tax Rate | 18.84% |
Stock Price Statistics
The stock price has decreased by -14.41% in the last 52 weeks. The beta is 0.68, so NSE:REMUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -14.41% |
| 50-Day Moving Average | 973.47 |
| 200-Day Moving Average | 1,107.41 |
| Relative Strength Index (RSI) | 36.95 |
| Average Volume (20 Days) | 7,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:REMUS had revenue of INR 6.20 billion and earned 290.70 million in profits. Earnings per share was 32.61.
| Revenue | 6.20B |
| Gross Profit | 874.90M |
| Operating Income | 438.20M |
| Pretax Income | 473.40M |
| Net Income | 290.70M |
| EBITDA | 456.90M |
| EBIT | 438.20M |
| Earnings Per Share (EPS) | 32.61 |
Balance Sheet
The company has 81.40 million in cash and 229.80 million in debt, giving a net cash position of -148.40 million or -12.59 per share.
| Cash & Cash Equivalents | 81.40M |
| Total Debt | 229.80M |
| Net Cash | -148.40M |
| Net Cash Per Share | -12.59 |
| Equity (Book Value) | 2.83B |
| Book Value Per Share | 423.08 |
| Working Capital | 998.40M |
Cash Flow
In the last 12 months, operating cash flow was 69.80 million and capital expenditures -111.20 million, giving a free cash flow of -41.40 million.
| Operating Cash Flow | 69.80M |
| Capital Expenditures | -111.20M |
| Free Cash Flow | -41.40M |
| FCF Per Share | -3.51 |
Margins
Gross margin is 14.10%, with operating and profit margins of 7.06% and 4.69%.
| Gross Margin | 14.10% |
| Operating Margin | 7.06% |
| Pretax Margin | 7.63% |
| Profit Margin | 4.69% |
| EBITDA Margin | 7.37% |
| EBIT Margin | 7.06% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.75, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 0.75 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 1.53% |
| Buyback Yield | 21.35% |
| Shareholder Yield | 21.43% |
| Earnings Yield | 2.81% |
| FCF Yield | -0.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 4, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Jul 4, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |